Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2003
06/04/2003EP1315492A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1315491A2 Method for treating allergies using substituted pyrazoles
06/04/2003EP1315490A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1315480A2 "slow release" pharmaceutical compositions comprising lithium carbonate
06/04/2003EP1216046B1 Novel combination of loteprednol and antihistamines
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0970084B1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0938496B1 Heptapeptide oxytocin analogues
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0672116B1 Deletion mutants as vaccines for cholera
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003CN1422277A Novel substance having physiological activity, process for producing the same, and use
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422230A Infusion packet with useful and decorative element, support member, delivery system and method
06/04/2003CN1422163A Formulation solubilizing water-insoluble agents and preparation method thereof
06/04/2003CN1422158A Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1422149A Pharmaceutical compositions
06/04/2003CN1421452A Structure and prepn of 2,6-branched oligosaccharide with medicinal application foreground
06/04/2003CN1421238A Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
06/04/2003CN1421212A Cell growth regulating factor J and its prepn process
06/04/2003CN1421211A Cell growth regulating factor M and its prepn process
06/04/2003CN1421210A Cell growth regulating factor P and its prepn process
06/04/2003CN1110557C LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idio type antibody
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/04/2003CN1110317C Production process of salt algae powder and its soft capsule
06/04/2003CN1110303C Application of eight precious extract in preparing antiviral medicine
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573293 Anticancer agents
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573273 Urea substituted imidazoquinolines
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573248 Monocyclic L-nucleosides, analogs and uses thereof
06/03/2003US6573245 Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
06/03/2003US6573236 Myelin oligodendrocyte glycoprotein (MOG) polypeptide-specific antibody to bind a natural MOG polypeptide and competitively inhibit the binding of an autoantibody, does not comprise functional Fc portion; multiple sclerosis
06/03/2003US6573079 Methods and interferon deficient substrates for the propagation of viruses
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6572867 Reducing plasma levels of anti-( alpha Gal(1,3)Gal) antibodies; nonimmunogenic polymers comprise alpha Gal(1,3) Gal moieties covalently linked to said polymer; cross-links are covalent tethers, derived from N-hydroxysulfosuccinimide
06/03/2003US6572861 Lecithin, oil in water emulsion and an amphiphilic surfactant; minimize local reactions to the vaccine
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
06/03/2003US6572852 Genetic engineering
06/03/2003CA2273446C Piperidones
06/03/2003CA2116224C Novel alpha-mannosidase inhibitors
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044053A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003WO2003044033A1 Novel immunosuppressants
05/30/2003WO2003044023A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044009A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043663A1 Compositions inhibiting rejection in organ transplantation and method of using the same
05/30/2003WO2003043657A1 Topical delivery of codrugs
05/30/2003WO2003043648A2 Sfcyr iib or sfcyr iii for the treatment of auto-immune diseases
05/30/2003WO2003043647A2 A plant extract active as an immunostimulating agent
05/30/2003WO2003043636A1 Nicotin-or isonicotin benzothiazole derivatives
05/30/2003WO2003043634A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003WO2003043621A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
05/30/2003WO2003043613A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
05/30/2003WO2003043604A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
05/30/2003WO2003043588A1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
05/30/2003WO2003043583A2 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003026691A3 Use of hmgb1 for the activation of dendritic cells
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2003005952A3 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
05/30/2003WO2003002106A3 Use of tyrosine kinase inhibitions for treating allergic diseases
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002078698A3 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
05/30/2003WO2002077029A3 Cd19-specific redirected immune cells
05/30/2003WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002062795A3 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
05/30/2003WO2002041871A9 Composition comprising an imexon or derivatives thereof and lipids
05/30/2003WO2002036148A3 Use of death receptor ligands or rip to initiate the non-caspase-dependent cell death and compounds for inhibition of the non-caspase-dependent cell death
05/30/2003WO2002034290A9 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001091792A3 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
05/30/2003WO2001087922A3 Derivatisation of proteins in aqueous solution
05/30/2003WO2001052874A9 Intra-tumoral administration of il-12 encoding nucleic acid molecules
05/30/2003CA2467915A1 Compositions inhibiting rejection in organ transplantation and method of using the same
1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 1172